1. Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors. Issue 5 (8th February 2021) Authors: Shi, Yao; Yuan, Juan; Rraklli, Vilma; Maxymovitz, Eva; Cipullo, Miriam; Liu, Mingzhi; Li, Shuijie; Westerlund, Isabelle; Bedoya-Reina, Oscar C; Bullova, Petra; Rorbach, Joanna; Juhlin, C Christofer; Stenman, Adam; Larsson, Catharina; Kogner, Per; O'Sullivan, Maureen J; Schlisio, Susanne; Holmberg... Journal: Nucleic acids research Issue: Volume 49:Issue 5(2021) Page Start: 2509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project. (3rd August 2017) Authors: Moreno, Lucas; Caron, Hubert; Geoerger, Birgit; Eggert, Angelika; Schleiermacher, Gudrun; Brock, Penelope; Valteau-Couanet, Dominique; Chesler, Louis; Schulte, Johannes H; De Preter, Katleen; Molenaar, Jan; Schramm, Alexander; Eilers, Martin; Van Maerken, Tom; Johnsen, John Inge; Garrett, Michell... Journal: Expert opinion on drug discovery Issue: Volume 12:Number 8(2017:Aug.) Page Start: 801 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements. Issue 1 (2nd September 2019) Authors: Javanmardi, Niloufar; Fransson, Susanne; Djos, Anna; Umapathy, Ganesh; Östensson, Malin; Milosevic, Jelena; Borenäs, Marcus; Hallberg, Bengt; Kogner, Per; Martinsson, Tommy; Palmer, Ruth H. Journal: Genes, chromosomes & cancer Issue: Volume 59:Issue 1(2020) Page Start: 50 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial. Issue 4 (April 2017) Authors: Ladenstein, Ruth; Pötschger, Ulrike; Pearson, Andrew D J; Brock, Penelope; Luksch, Roberto; Castel, Victoria; Yaniv, Isaac; Papadakis, Vassilios; Laureys, Geneviève; Malis, Josef; Balwierz, Walentyna; Ruud, Ellen; Kogner, Per; Schroeder, Henrik; de Lacerda, Ana Forjaz; Beck-Popovic, Maja; Bician,... Journal: Lancet oncology Issue: Volume 18:Issue 4(2017:Apr.) Page Start: 500 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors. (17th February 2018) Authors: Georgantzi, Kleopatra; Sköldenberg, Erik G.; Stridsberg, Mats; Kogner, Per; Jakobson, Åke; Janson, Eva Tiensuu; Christofferson, Rolf H. B. Journal: Pediatric hematology and oncology Issue: Volume 35:Number 2(2018) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor‐stroma drug targeting. Issue 8 (5th July 2020) Authors: Kock, Anna; Bergqvist, Filip; Steinmetz, Julia; Elfman, Lotta H. M.; Korotkova, Marina; Johnsen, John Inge; Jakobsson, Per‐Johan; Kogner, Per; Larsson, Karin Journal: FASEB journal Issue: Volume 34:Issue 8(2020) Page Start: 11101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Filamin A increases aggressiveness of human neuroblastoma. Issue 1 (28th February 2022) Authors: Bandaru, Sashidar; Prajapati, Bharat; Juvvuna, Prasanna Kumar; Dosa, Sandor; Kogner, Per; Johnsen, John I; Kanduri, Chandrasekhar; Akyürek, Levent M Journal: Neuro-oncology advances Issue: Volume 4:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1). Issue 30 (20th October 2021) Authors: Bellini, Angela; Pötschger, Ulrike; Bernard, Virginie; Lapouble, Eve; Baulande, Sylvain; Ambros, Peter F.; Auger, Nathalie; Beiske, Klaus; Bernkopf, Marie; Betts, David R.; Bhalshankar, Jaydutt; Bown, Nick; de Preter, Katleen; Clément, Nathalie; Combaret, Valérie; Font de Mora, Jaime; George, Sal... Journal: Journal of clinical oncology Issue: Volume 39:Issue 30(2021) Page Start: 3377 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target?. Issue 10 (13th July 2013) Authors: Wolmer‐Solberg, Nina; Baryawno, Ninib; Rahbar, Afsar; Fuchs, Dieter; Odeberg, Jenny; Taher, Chato; Wilhelmi, Vanessa; Milosevic, Jelena; Mohammad, Abdul‐Aleem; Martinsson, Tommy; Sveinbjörnsson, Baldur; Johnsen, John Inge; Kogner, Per; Söderberg‐Nauclér, Cecilia Journal: International journal of cancer Issue: Volume 133:Issue 10(2013:Nov. 15) Page Start: 2351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors. Issue 1 (2nd January 2016) Authors: Olsson, Maja; Beck, Stephan; Kogner, Per; Martinsson, Tommy; Carén, Helena Journal: Epigenetics Issue: Volume 11:Issue 1(2016) Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗